Improved nitrogen utilization in cattle is important in order to secure a sustainable cattle production. 25
throughout. 165

LC-MS/MS analysis 167
Chromatographic separation was performed on an Agilent 1100 series HPLC system (Agilent 168
Technologies, Hørsholm, Denmark) with a Synergi™ Hydro-RP LC Column (250 mm × 2 mm, 4 169 µm) protected by a conventional guard column of the same material purchased from Phenomenex 170 (Vaerløse, Denmark). Samples were analyzed in five separate runs, three in negative electrospray 171 (ESI) mode and two in positive ESI mode. The five groups of metabolites and their 172 chromatographic profiles are shown in Table 2 . Separation was performed using a gradient solvent 173 system. For each run, HPLC solvents were freshly prepared and cleared on a 0.45 µm Pall 174 hydrophilic polypropylene membrane filter purchased from VWR. Both solvents (A) and (B) were 175 prepared from a 0.05 mol/L acetic acid buffer containing 10% or 50% methanol, respectively. The 176 acetic acid buffer was prepared by adjusting 0.05 mol/L acetic acid to pH 4.0 with ammonium 177 solution and readjusting to pH 2.8 with formic acid. The following elution gradient was used: initial 178 percentage of solvent B was 5%, this was raised to 100% in 8 min and kept there for 6 min, then 179 lowered to 5% in 30 sec, after which it was kept constant for 3.5 min to re-equilibrate the column 180 prior to the next injection. The flow rate was 200 µL/min and the injection volume was 5 µL. The 181 column temperature was maintained at 30°C while the auto sampler temperature was set to 4°C to 182 stabilize the samples during time-consuming analyses. The total run time was 18 min per sample. 183 Table 2  185 186 electrospray mass spectrometric analyses using massLynx 4.0 (Waters) software for data collection 188 and processing. Capillary voltage was set to 3.2 kV, source temperature to 120°C, and desolvation 189 temperature to 400°C. The cone and desolvation gas flows (nitrogen and argon) were set at 29 and 190 628 L/hour, respectively. Fragment ion spectra were recorded in both polarities and promising 191 selective fragment ions were tested and optimized along with the cone voltage in multiple-reaction 192 monitoring (MRM) mode. The values of the tune parameters were optimized by separately infusing 193 a solution (500 µmol/L) of each metabolite in its mobile phase at a flow rate of 10 µL/min. The 194 MRM transitions and the applied cone voltages and collision energies are summarized in Table 3 . 195 Common transitions were originated from the loss of HCN, NH3, ribose, deoxyribose, HNCO, 196 HNCONH2 and H2O fragments for the various PP metabolites ( Table 1 ). The most intense 197 transition reaction was used for quantification (Table 3) 
Calibration and quantification 203
Quantification was performed by matrix-matched external calibration applying standard plasma 204 spiked with a two-fold serial dilution of mixed standard solutions to obtain seven different 205 concentration levels of each compound. The only exception was with uracil where a two-third-fold 206 serial dilution was applied. Standard plasma (not spiked) was used for subtraction and quality 207 control but was not included in the regression analysis. In general, all samples and calibrators were 208 analyzed in duplicate and a standard curve and quality control samples were analyzed at the 209 beginning and at the end of each sequence. The response was calculated as the chromatographic 210 peak area for all compounds. When applying standard plasma, which contained unknown quantitiesof the metabolites under investigation, the measured metabolite response was initially normalized 212 and the response from the standard plasma was subtracted. The mean of the measured SIL 213 responses/SIL area for each sample was used as the normalization factor. During method 214 development the focus of work was on quantifying as low concentrations of metabolite as possible. 215
Matrix-matched calibration curves, within the relevant concentration ranges given in Table 4 , were 216 generated for each metabolite at four (allantoin) or seven concentration levels on five consecutive 217 days for determining and evaluating the calibration model. As noted previously, uric acid and uracil 218 were quantified from diluted samples. The coefficient of variation (CV%) for each concentrate level 219 was then calculated for a logarithmic and a linear calibration model to test the use of log-log 220 transformation. The linearity of the log calibration curves were studied with a lack of fit hypothesis 221 test. Subsequently, the homogeneity of variance was estimated for each concentration by plotting 222 the CV% against log(concentration) and the quantification range set to the lowest and highest 223 quantified concentration giving a CV% below 25%. 224 225 [29] . It was validated with respect to 231 assessment of selectivity, stability, precision, recovery, and matrix effect. 232
Selectivity: Metabolite and SIL cross-talk was evaluated by analyzing the standard compounds 233 alone and together with their corresponding SIL (no blank matrix was available). Three groups were 234 (10% v/v, 50 µmol/L), and a combined group (5% v/v, 25 µmol/L). Analyses of BS/DP and NS 236 were carried out separately. 237
Stability: For continuous evaluation of long-term storage stability, a fresh quality control sample 238 was analyzed in all analytical runs. The stability within runs (6-24 h) was evaluated in two ways. 239
First, a quality control sample was analyzed at the beginning and at the end of each sequence (data 240 not shown). Secondly, a set of spiked standard plasma samples were analyzed at five different times 241 (different vials) during a 30 hour sequence. Analysis of variance (ANOVA) using linear mixed 242 models procedures was used to test the stability over time, both with a trend element and with 243 random changes over and above the linear trend (regression line) [30, 31] . Applying ANOVA, the 244 across-day variation of the PP calibration curves (intercepts and slopes as interactions with test day) 245
was assessed over five consecutive days and expressed by their P-values. The stability during 246 repeated freeze-thaw cycles was not explored since all plasma samples in the present study were 247 only thawed once. 248
Precision and recovery: Precision of the method, in terms of within-day variation (repeatability) 249 and across-day variation (intermediate precision), was determined by analyzing replicate sets of 250 spiked standard plasma samples on five separate days expressed as their CV%. The absolute 251 recoveries were calculated using the same set of spiked standard plasma, at one level, by comparing 252 the obtained concentrations with the initial spiked level. 253
Matrix effect: Early tests with spiked water, urine and plasma samples revealed large variations in 254 matrix effect-induced signal suppression and enhancement between the metabolites included in the 255 analysis. Following optimization of the pre-treatment procedure, these matrix effects were 256 evaluated as the difference between samples of water and standard plasma, urine or milk samples 257 spiked with constant amounts of SIL before pre-treatment. Thus, we took advantage of the fact that 258 the incorporated SIL should behave as their matching metabolite in the ESI source [27] . Theconventional strategy of spiking a blank matrix sample with a compound standard was again not 260 possible as completely blank matrices were not available for these metabolites. The applied SIL-261 based method was a modified version of the conventional method to evaluate matrix effect 262 described by Matuszewski et al. [32] . The observed matrix effect was rendered insignificant by 263 utilizing matrix-matched external calibration. 264 265
Application 266
To determine the application range of the method, the relative matrix effect was evaluated by 267 comparing the response from PP SIL spiked in standard jugular vein plasma with the response in 268 test plasma samples. Four different sets of samples were assessed. First, plasma from the jugular 269 vein of four multicatheterized cows was used to investigate within-species variation. Next, plasma 270 drawn from the portal vein, the hepatic vein, the gastrosplenic vein, and an artery from a 271 multicatheterized dairy cow to represent different possible sampling sites were examined. Third, 272 plasma samples from different species (chicken, pig, mink, human, rat) were used for between-273 species evaluation. Finally, water, urine and milk samples were used to compare different matrices. 274
The relative recovery determined which of the tested matrices were suitable for the method. For the 275 same reasons as described previously, SIL replaced compound standards. Water, urine and milk 276 samples were evaluated in the same manner as plasma samples. 277 cross-talk [33, 34] as well as matrix effects [35] and at the same time enhances both the selectivity 298 and the sensitivity of the analysis [29] . A novel multi-step approach, consisting of protein 299 precipitation, ultrafiltration, evaporation under nitrogen flow, and subsequent resolution, able to 300 purify and to concentrate all of the studied metabolites from bovine plasma simultaneously, in a 301 simple and efficient manner, was developed and optimized. 302
Initially, different solvents (acetone, acetonitrile, ethanol, methanol, sulfo-salicylic acid) were tested 303 for precipitation (data not shown). Ethanol precipitation resulted in the highest recoveries and least 304 noise when comparing chromatographic responses and this less harmful solvent was therefore 305 chosen for the procedure. The ultrafiltration step was added as this step caused markedly lower 306 treatment, evaporation and reconstitution steps were included. Overall this resulted in a 1.4 times 308 concentration effect. To try to reduce degradation and instability of the samples caused by reactive 309 oxygen species or enzyme activities during pre-treatment, all centrifugations and incubations were 310 performed at 4°C and samples, stocks, and solvents etc. were kept at -4°C or on ice. Only during 311 evaporation were the samples maintained at room temperature. Other types of pre-treatment 312 methods such as simple dilution (impractical), solid phase extraction (different chemical properties) 313
[36,37] and accelerated solvent extraction [38] were also investigated (data not shown) but were not 314 found useful. 315
The effectiveness of the pre-treatment and the stability of the metabolites during the multiple steps 316
were evaluated during validation of the method, described in section 3.3, and demonstrated the 317 ability of this pre-treatment to purify and concentrate all of the targeted PP simultaneously in an 318 easy and efficient manner without significant losses. To our knowledge, no other publications have 319 presented a similar and effective pre-treatment procedure, as most other approaches include dilution 320 of the samples. 321 322
LC-MS/MS procedure 323
Based on the chemical properties of the targeted metabolites, experiences from similar studies 324 [14, 39] , and available equipment, a reversed-phase C18 column known to be able to quantify the 325 majority of the studied metabolites from urine was applied with an acetic acid buffer/methanol 326 HPLC solvent system. 327
To achieve adequate separation and elution order, a series of conditions were modified and 328 were with allantoin, β-ureidopropionic acid, cytosine and β-alanine, their CV% at the high end of 356 their profiles were better without the log-log transformation. Given that quantification at low 357 concentrations was considered to be most important, these findings validated the use of log-log 358 transformation in the analysis of all the applied PPs. Performing a lack of fit test, the linearity of the 359 PP calibration curves were evaluated and expressed by their P-values (Table 4) . None of the PP 360 curves resulted in a significant lack of fit except uridine, which had a very low sensitivity in the 361 analysis, demonstrating a satisfying log-log regression. 362
The homogeneity of variance for the different concentration levels is illustrated in Figure 2 and the 363 quantification ranges (CV<25%) in Table 4 . Focusing on the lower concentration range, most of the 364 PP demonstrated a typical precision profile where the CV% decreased with higher concentration 365 levels. All purines had acceptable variation levels around the lowest concentration levels except 366 allantoin, which should not be quantified at concentrations below ~100 µmol/L. The pyrimidine BS 367 and cytidine and uridine had larger CV%'s with acceptable lower concentration levels from 0.66-368 5.15 µmol/L. Thymidine and 2'-deoxyuridine demonstrated a very large variation with CV%'s 369 above 25% over the entire concentration range. In the case of the pyrimidine DP, they were 370 reasonably stable over their concentration ranges, not counting β-alanine which only had a 371 CV%<25% at its highest calibrator. The upper part of the quantification range was in all cases the 372 highest quantified calibrator. 373 plasma. In terms of quantification purposes, selectivity, stability, precision, recovery, and matrix 380 effects were evaluated. 381
The most intensive fragment ion from each precursor ion was selected as the transition ion for 382 detection and quantification. Positive identification was based on the correlation of retention time 383
with the standards and the selected precursor/product transition. Less intensive second transitions 384 were used for confirmation. All metabolites generated single peak shapes. 385 386
Selectivity 387
A blank sample for selectivity evaluation was not available for these naturally occurring plasma 388 metabolites. Hence, the presence of chromatographic peaks from standard plasma at the same 389 retention times as the targeted metabolites could not be excluded; such endogenous peaks would be 390 expected to be present. Instead, the absence of standard compound/SIL cross-talk contributions was 391 verified by comparing chromatographic responses for standards and SIL alone and in a mixture 392 (data not shown). It was important to assess cross-talk contributions, as some of the applied SIL 393 (Table 3) had less than three mass unit differences (3-8) to the natural metabolite, which is normally 394 recommended as the lowest mass unit difference for LC-MS/MS analysis [33, 34] . 395 396
Stability 397
Good stability was achieved by optimizing the pre-treatment and LC-MS/MS parameters as 398 described in section 3.1. Long-term storage stability was tested by comparing chromatographic 399 profiles of quality control standard plasma on a daily basis. Within-run stability was evaluated by 400 analyzing a control sample at the beginning and end of each sequence. Long sequence run times 401 have been of concern and the within-run stability was consequently also evaluated by performing 402 ANOVA for measurements made at times 0, 7, 15, 22 and 29 hours, during a 30 hour sequence with 403 triplicate determinations at each time-point, using either a slope model: yij = intercept + 404 b*time_hour + εij, or a combined model: yij = intercept + timei + b*time_hour + εij, where yij is the 405 area measured in the sample at time i, replicate j, and b is the slope of the area change per hour, and 406 εij is the random error term. Significance of the time effects were tested using an F-test with type 1 407 sum of squares. Residual mean square error was calculated as the square of the residual variance 408 estimate and expressed as CV%. The metabolite responses were normalized as usual but the SIL 409 responses were not since they could not be used to normalize themselves. The results are given in 410 Table 5 . 411
In general, the combined model resulted in lower CV%'s than the slope model, as the irregular time 412 effect was also taken into consideration in the combined model. All but a few metabolites 413 demonstrated very stable profiles over the 30 hour time span with CV%≤10%. Exceptions were 414 thymidine (136%), 2'-deoxyuridine (46%) and β-alanine (13%), where especially the former two 415 were found to be unstable. This was probably due to low sensitivities in the analysis. The SILs were 416 found to be equally or more stable than their corresponding metabolites probably due to their higher 417 spike concentrations. As expected, thymidine (U- 
Precision and recovery 432
To ensure correct quantification and to evaluate analytical precision, within-day and across-day 433 variation was determined by studying replicate sets of spiked standard plasma samples (n = 8, 434 samples) on five separate days (m = 5, days). Here, precision was defined as the degree to which 435 repeated measurements under unchanged conditions showed the same result, expressed as the CV%. 436
Absolute recoveries were identified by using the same set of spiked standard plasma samples, 437 comparing the recovered quantified concentrations with the initial spiked concentrations. Since 438 linearity ranges were short and close to zero, a single, instead of the traditional three, recovery 439 concentration levels was chosen. Precision and recovery outcomes are given in Table 6 . The 440 obtained results showed very good extraction efficiency and precision. The recoveries were 441 between 91% and 107%, except for uric acid with a lower recovery of 78%. Also, the low 442 sensitivity and accompanying instability of cytidine, thymidine and 2'-deoxyuridine was again 443 highlighted with recoveries of 162%, 121%, and 149%, respectively. In general, the within-and 444 across-day variations mirrored the recovery results. The exceptions were with allantoin and 445 cytosine, both of which had good recoveries, 107% and 103%, but exhibited large CV%'s, within-446 day variation 34% and 21%, and across day variation 49% and 24%, respectively. 447 Table 6  449 It is useful to distinguish between two types of matrix effects: absolute matrix effect, which is the 452 difference in response between an undiluted solution and a post-extraction spiked sample, and 
Analytical application (relative matrix effect) 487
This LC-MS/MS analysis was established for quantification of 20 target metabolites of the PP 488 metabolism in blood plasma samples from multicatheterized cows. Since jugular vein plasma 489 (representing systemic circulating blood) was used for method development and because 490 quantification relied on matrix-matched calibration (jugular vein plasma), the relative matrix effect 491 was evaluated in alternative types of plasma. The relative matrix effect was evaluated by comparing 492 the response from SIL spiked in standard jugular vein plasma with the response in tested plasma 493 samples. A relative recovery between 85% and 115% was considered good and between 75% and 494 125% acceptable, hence, tested samples exerted the same matrix effect on the metabolite as the cow 495 jugular vein plasma sample. The generosity of 75-125% was due to the small sample size (n = 2 496 samples) inevitably resulting in less precision. The PP responses given as recovery (%) are depictedin Table 7 . 498
First of all, it was confirmed that within-species variation was not an issue with any of the 499 metabolites examined, except for uridine. Secondly, the results demonstrated that all the examined 500 metabolites, evaluated in all four plasma types from feeding experiments with multicatheterized 501 cows with this particular type of cow model, could appropriately be quantified with the developed 502 LC-MS/MS method. Only xanthine (67%), uridine (135%/148%/127%) and thymidine (132%) 503 displayed recoveries outside the acceptable range of 75-125% and especially thymidine will be hard 504 to quantify with this method due to other issues anyway. Surprisingly, the between-species range 505 was very broad and most metabolites could be evaluated in plasma from other species tested with a 506 few exceptions. Further confirmed was also the results from section 3.3.5, concluding that matrix 507 effects varied significantly between different types of matrices such as water, plasma, urine and 508 milk. Hence, it is necessary to design, optimize and validate a specific LC-MS/MS method for each 509 applied matrix. 510 
Conclusions 514
This work presents the development and validation of a new method for simultaneous and accurate 515 quantification of 20 targeted metabolites of PP metabolism with different structures and physio-516 chemical properties in blood plasma from dairy cows. Exceptions were with cytidine, thymidine 517 and 2'-deoxyuridine, where the method's sensitivity for these three PP metabolites was so low that 518 they caused imprecise quantification over the examined concentration ranges. The metabolites were 519 purified and concentrated using a novel multi-step pre-treatment procedure consisting of protein 520 area against concentration (linear calibration) and using linear regression of log(area) against 656 log(concentration) (log-calibration). Panel I present the 13 purines and pyrimidines that 657 considerably improved their CV% profiles using the log-calibration. Panel II, present the seven 658 purines and pyrimidines that did not benefit from the log transformation. Abbreviations for the 20 659 metabolites: Ade, adenine; Gua, guanine; Guo, guanosine; Ino, inosine; dGuo, 2'-deoxyguanosine; 660 dIno, 2'-deoxyinosine; Xan, xanthine; Hyp, hypoxanthine; Uac, uric acid; All, allantoin; Urd, 661 uridine; β-ure, β-ureidopropionic acid; β-ami, β-aminoisobutyric acid; Cyt, cytosine; Thy, thymine; 662 Ura, uracil; Cyd, Cytidine; Thd, thymidine; dUrd, 2'-deoxyuridine; β-ala, β-alanine. 663 664 Fig. 2 . The homogeneity of variance for the different concentration levels of the purine and 665 pyrimidine calibration curves divided into bases, nucleosides and degradation products (CV%). 666
Abbreviations for the 20 metabolites: Ade, adenine; Gua, guanine; Guo, guanosine; Ino, inosine; 667 dGuo, 2'-deoxyguanosine; dIno, 2'-deoxyinosine; Xan, xanthine; Hyp, hypoxanthine; Uac, uric 668 acid; All, allantoin; Urd, uridine; β-ure, β-ureidopropionic acid; β-ami, β-aminoisobutyric acid; Cyt, 669 cytosine; Thy, thymine; Ura, uracil; Cyd, Cytidine; Thd, thymidine; dUrd, 2'-deoxyuridine; β-ala, 670 β-alanine. 
Table 2
The 20 metabolites were divided into five groups and run according to ESI -/+ mode and structure 
